NKTR - Nektar Therapeutics Q2 2023 Earnings Preview
2023-08-07 17:35:20 ET
- Nektar Therapeutics ( NASDAQ: NKTR ) is scheduled to announce Q2 earnings results on Tuesday, August 8th, after market close.
- The consensus EPS Estimate is -$0.22 and the consensus Revenue Estimate is $21.83M (+1.1% Y/Y).
For further details see:
Nektar Therapeutics Q2 2023 Earnings Preview